Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Panitumumab in the Treatment of Carcinoid Syndrome

This study has been withdrawn prior to enrollment.
(Study never began)
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Boston Medical Center
ClinicalTrials.gov Identifier:
NCT01172717
First received: July 28, 2010
Last updated: July 25, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: July 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)